SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

NCT05733845 ·Status: RECRUITING ·Phase: NA

Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease

NCT02181153 ·Status: COMPLETED ·Phase: NA

Genetic Studies of Inflammatory Bowel Disease

NCT00340444 ·Status: COMPLETED

An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)

NCT00988832 ·Status: COMPLETED

Personalising Anti-TNF Therapy in Crohns Disease (PANTS)

NCT03088449 ·Status: UNKNOWN

Joint Pain Occurring During Anti-TNF Therapy in Chronic Inflammatory Bowel Disease

NCT02899871 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03844932 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease

NCT06274996 ·Status: COMPLETED

Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy

NCT03359642 ·Status: COMPLETED ·Phase: NA

Immunological Characteristics of Preclinical IBD

NCT05698745 ·Status: RECRUITING

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

NCT01861249 ·Status: TERMINATED ·Phase: PHASE2

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

NCT01291810 ·Status: COMPLETED ·Phase: PHASE2

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

NCT02508012 ·Status: COMPLETED ·Phase: NA

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

NCT05406934 ·Status: UNKNOWN

Multi-omics to Predict Responses to Biologics in IBD

NCT05542459 ·Status: UNKNOWN

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

NCT02904590 ·Status: COMPLETED

Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease

NCT03885713 ·Status: COMPLETED ·Phase: PHASE4

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

NCT06655415 ·Status: RECRUITING

Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease

NCT00561548 ·Status: TERMINATED ·Phase: NA

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

NCT05596422 ·Status: COMPLETED

GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation )

NCT02994836 ·Status: COMPLETED ·Phase: PHASE4

A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis

NCT01453491 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 ·Status: TERMINATED ·Phase: PHASE2